[Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?]
- PMID: 27032759
- DOI: 10.1016/j.gyobfe.2016.02.016
[Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?]
Abstract
Introduction: Trisomy 21 (T21) is the most common chromosomal abnormality and one of the main causes of intellectual disability. The tumor profile of T21 patients is characterized by the low frequency of solid tumors including breast cancer.
Methods: The objective of this work was to analyze the literature to find possible clues for the low frequency of breast cancer in T21 persons with a focus on one hand to the various risks and protective factors against breast cancer for women T21, and on the other hand to changes in the expression of different genes located on chromosome 21.
Results: T21 women have hormonal and societal risk factors for breast cancer: frequent nulliparity, lack of breastfeeding, physical inactivity and high body mass index. The age of menopause, earlier in T21 women, has a modest protective effect against breast cancer. The low rate of breast tumors in T21 women is probably mainly linked to the reduced life expectancy compared to the general population (risk of death before the age of onset of the majority of breast cancers) and the presence of a third chromosome 21, characterizing the disease. It might lead to the increased expression of a number of genes contributing directly or undirectly to tumor suppression, decreased tumor angiogenesis and increased cell apoptosis. Moreover, changes in the mammary stroma of persons T21 could have an inhibitory role on the development of breast tumors.
Conclusion: The low frequency of breast cancers for T21 patients may not only be explained by hormonal and societal factors, but also by genetic mechanisms which could constitute an interesting axis of research in breast cancer.
Keywords: Breast cancer; Cancer du sein; Down syndrome; PS2-TFF1; PS2/TFF1; Syndrome de Down; Trisomie 21; Trisomy 21.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Transcriptomic study in women with trisomy 21 identifies a possible role of the GTPases of the immunity-associated proteins (GIMAP) in the protection of breast cancer.Sci Rep. 2020 Jun 10;10(1):9447. doi: 10.1038/s41598-020-66469-w. Sci Rep. 2020. PMID: 32523132 Free PMC article.
-
[Breast cancer in women with trisomy 21].Bull Acad Natl Med. 2001;185(7):1239-52; discussion 1252-4. Bull Acad Natl Med. 2001. PMID: 11975321 French.
-
Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta.Placenta. 2016 Jun;42:17-24. doi: 10.1016/j.placenta.2016.03.012. Epub 2016 Mar 24. Placenta. 2016. PMID: 27238709
-
Down syndrome-associated periodontitis: a critical review of the literature.Compend Contin Educ Dent. 2012 May;33(5):356-61. Compend Contin Educ Dent. 2012. PMID: 22616218 Review.
-
[Can breast cancer be prevented?].Tidsskr Nor Laegeforen. 1991 May 30;111(14):1745-8. Tidsskr Nor Laegeforen. 1991. PMID: 2063386 Review. Norwegian.
Cited by
-
From Churchill to Elephants: The Role of Protective Genes against Cancer.Genes (Basel). 2024 Jan 18;15(1):118. doi: 10.3390/genes15010118. Genes (Basel). 2024. PMID: 38255007 Free PMC article. Review.
-
Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review.Front Genet. 2021 Nov 5;12:749480. doi: 10.3389/fgene.2021.749480. eCollection 2021. Front Genet. 2021. PMID: 34804119 Free PMC article. Review.
-
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.Int J Mol Sci. 2017 Jun 7;18(6):1218. doi: 10.3390/ijms18061218. Int J Mol Sci. 2017. PMID: 28590426 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical